465 related articles for article (PubMed ID: 23686307)
1. Brd4 maintains constitutively active NF-κB in cancer cells by binding to acetylated RelA.
Zou Z; Huang B; Wu X; Zhang H; Qi J; Bradner J; Nair S; Chen LF
Oncogene; 2014 May; 33(18):2395-404. PubMed ID: 23686307
[TBL] [Abstract][Full Text] [Related]
2. Bromodomain and extraterminal (BET) protein inhibition suppresses human T cell leukemia virus 1 (HTLV-1) Tax protein-mediated tumorigenesis by inhibiting nuclear factor κB (NF-κB) signaling.
Wu X; Qi J; Bradner JE; Xiao G; Chen LF
J Biol Chem; 2013 Dec; 288(50):36094-105. PubMed ID: 24189064
[TBL] [Abstract][Full Text] [Related]
3. Brd4 coactivates transcriptional activation of NF-kappaB via specific binding to acetylated RelA.
Huang B; Yang XD; Zhou MM; Ozato K; Chen LF
Mol Cell Biol; 2009 Mar; 29(5):1375-87. PubMed ID: 19103749
[TBL] [Abstract][Full Text] [Related]
4. The Brd4 acetyllysine-binding protein is involved in activation of polyomavirus JC.
Wollebo HS; Bellizzi A; Cossari DH; Salkind J; Safak M; White MK
J Neurovirol; 2016 Oct; 22(5):615-625. PubMed ID: 27007123
[TBL] [Abstract][Full Text] [Related]
5. An optimized BRD4 inhibitor effectively eliminates NF-κB-driven triple-negative breast cancer cells.
Yang GJ; Song YQ; Wang W; Han QB; Ma DL; Leung CH
Bioorg Chem; 2021 Sep; 114():105158. PubMed ID: 34378541
[TBL] [Abstract][Full Text] [Related]
6. Affinity map of bromodomain protein 4 (BRD4) interactions with the histone H4 tail and the small molecule inhibitor JQ1.
Jung M; Philpott M; Müller S; Schulze J; Badock V; Eberspächer U; Moosmayer D; Bader B; Schmees N; Fernández-Montalván A; Haendler B
J Biol Chem; 2014 Mar; 289(13):9304-19. PubMed ID: 24497639
[TBL] [Abstract][Full Text] [Related]
7. Bromodomain-containing protein 4-independent transcriptional activation by autoimmune regulator (AIRE) and NF-κB.
Huang F; Shao W; Fujinaga K; Peterlin BM
J Biol Chem; 2018 Apr; 293(14):4993-5004. PubMed ID: 29463681
[TBL] [Abstract][Full Text] [Related]
8. BET Inhibition Attenuates Helicobacter pylori-Induced Inflammatory Response by Suppressing Inflammatory Gene Transcription and Enhancer Activation.
Chen J; Wang Z; Hu X; Chen R; Romero-Gallo J; Peek RM; Chen LF
J Immunol; 2016 May; 196(10):4132-42. PubMed ID: 27084101
[TBL] [Abstract][Full Text] [Related]
9. Bromodomain-containing protein 4 inhibition alleviates matrix degradation by enhancing autophagy and suppressing NLRP3 inflammasome activity in NP cells.
Hong J; Li S; Markova DZ; Liang A; Kepler CK; Huang Y; Zhou J; Yan J; Chen W; Huang D; Xu K; Ye W
J Cell Physiol; 2020 Jul; 235(7-8):5736-5749. PubMed ID: 31975410
[TBL] [Abstract][Full Text] [Related]
10. BRD4 mediates NF-κB-dependent epithelial-mesenchymal transition and pulmonary fibrosis via transcriptional elongation.
Tian B; Zhao Y; Sun H; Zhang Y; Yang J; Brasier AR
Am J Physiol Lung Cell Mol Physiol; 2016 Dec; 311(6):L1183-L1201. PubMed ID: 27793799
[TBL] [Abstract][Full Text] [Related]
11. BRD4 Couples NF-κB/RelA with Airway Inflammation and the IRF-RIG-I Amplification Loop in Respiratory Syncytial Virus Infection.
Tian B; Yang J; Zhao Y; Ivanciuc T; Sun H; Garofalo RP; Brasier AR
J Virol; 2017 Mar; 91(6):. PubMed ID: 28077651
[TBL] [Abstract][Full Text] [Related]
12. The BRD4 inhibitor JQ1 protects against chronic obstructive pulmonary disease in mice by suppressing NF-κB activation.
Liu Y; Huang ZZ; Min L; Li ZF; Chen K
Histol Histopathol; 2021 Jan; 36(1):101-112. PubMed ID: 33215396
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of Bromodomain and Extraterminal Domain Family Proteins Ameliorates Experimental Renal Damage.
Suarez-Alvarez B; Morgado-Pascual JL; Rayego-Mateos S; Rodriguez RM; Rodrigues-Diez R; Cannata-Ortiz P; Sanz AB; Egido J; Tharaux PL; Ortiz A; Lopez-Larrea C; Ruiz-Ortega M
J Am Soc Nephrol; 2017 Feb; 28(2):504-519. PubMed ID: 27436852
[TBL] [Abstract][Full Text] [Related]
14. Nitric oxide antagonism to glioblastoma photodynamic therapy and mitigation thereof by BET bromodomain inhibitor JQ1.
Fahey JM; Stancill JS; Smith BC; Girotti AW
J Biol Chem; 2018 Apr; 293(14):5345-5359. PubMed ID: 29440272
[TBL] [Abstract][Full Text] [Related]
15. Duration of nuclear NF-kappaB action regulated by reversible acetylation.
Chen Lf ; Fischle W; Verdin E; Greene WC
Science; 2001 Aug; 293(5535):1653-7. PubMed ID: 11533489
[TBL] [Abstract][Full Text] [Related]
16. JQ1, a BET inhibitor, controls TLR4-induced IL-10 production in regulatory B cells by BRD4-NF-κB axis.
Lee MB; Lee JH; Hong SH; You JS; Nam ST; Kim HW; Park YH; Lee D; Min KY; Park YM; Kim YM; Kim HS; Choi WS
BMB Rep; 2017 Dec; 50(12):640-646. PubMed ID: 29187284
[TBL] [Abstract][Full Text] [Related]
17. BRD4 has dual effects on the HMGB1 and NF-κB signalling pathways and is a potential therapeutic target for osteoarthritis.
Jiang Y; Zhu L; Zhang T; Lu H; Wang C; Xue B; Xu X; Liu Y; Cai Z; Sang W; Hua Y; Ma J
Biochim Biophys Acta Mol Basis Dis; 2017 Dec; 1863(12):3001-3015. PubMed ID: 28844955
[TBL] [Abstract][Full Text] [Related]
18. Central Role of the NF-κB Pathway in the
Tian B; Yang J; Zhao Y; Ivanciuc T; Sun H; Wakamiya M; Garofalo RP; Brasier AR
J Virol; 2018 Jun; 92(11):. PubMed ID: 29593031
[TBL] [Abstract][Full Text] [Related]
19. Targeting BRD4 proteins suppresses the growth of NSCLC through downregulation of eIF4E expression.
Gao Z; Yuan T; Zhou X; Ni P; Sun G; Li P; Cheng Z; Wang X
Cancer Biol Ther; 2018 May; 19(5):407-415. PubMed ID: 29333921
[TBL] [Abstract][Full Text] [Related]
20. Transcriptome analysis of dominant-negative Brd4 mutants identifies Brd4-specific target genes of small molecule inhibitor JQ1.
Decker TM; Kluge M; Krebs S; Shah N; Blum H; Friedel CC; Eick D
Sci Rep; 2017 May; 7(1):1684. PubMed ID: 28490802
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
